📰 Lpcn News
Page 3 - Lpcn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lpcn. Real-time updates on events, politics, business and more.
September 8, 2023
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note issued to investors on Monday morning. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 4.5 % Shares of Lipocine stock opened at $3.65 on Monday. Lipocine has a 12 month low of $3.30 […]
September 7, 2023
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report issued on Monday morning. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 4.3 % Shares of NASDAQ LPCN opened at $3.82 on Monday. Lipocine has a twelve month low of $3.30 and a twelve […]
August 23, 2023
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note published on Saturday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Lipocine stock opened at $4.16 on Friday. The stock has a market cap of $22.11 million, a price-to-earnings ratio of -1.75 and […]
August 12, 2023
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Up 1.4 % Shares of LPCN opened at $5.08 on Friday. Lipocine has a 12 month low of $3.30 and […]
August 12, 2023
Lipocine Inc. (NASDAQ:LPCN – Get Free Report) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $5.70 and traded as low as $4.90. Lipocine shares last traded at $5.01, with a volume of 25,765 shares traded. Analyst Ratings Changes Separately, StockNews.com began coverage on […]
August 5, 2023
Research analysts at StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “buy” rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of NASDAQ:LPCN opened at $5.09 on Thursday. Lipocine has a 52 week low of $3.30 […]
July 29, 2023
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report issued on Wednesday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance LPCN opened at $4.91 on Wednesday. The stock’s fifty day moving average is $4.65 and its 200-day moving average is $5.97. Lipocine has […]
July 22, 2023
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of Lipocine stock opened at $4.24 on Tuesday. Lipocine has a 1 year low of $3.30 and a […]
July 13, 2023
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report released on Monday. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance NASDAQ:LPCN opened at $4.42 on Monday. Lipocine has a 1 year low of $3.30 and a 1 year high of $14.28. The […]
July 11, 2023
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report report published on Monday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 2.9 % NASDAQ:LPCN opened at $4.29 on Monday. The firm has a market cap of $22.31 million, a P/E ratio […]